Applying Risk-Based Oversight to Ensure Real-World Data Integrity

Clinical trials have undergone a period of immense change. Use of real-world data (RWD) is increasing. Regulators are backing both risk-based approaches and the use of real-world evidence (RWE). Artificial intelligence (AI) allows us to unlock better insights than ever before.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Press Release

CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins

The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category....

Press Release

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...

Press Release

CluePoints Appoints Martin Magazzolo as Chief Commercial Officer

Wayne, PA – July 27, 2026 – CluePoints, provider of leading statistical and AI-driven software solutions,...